In contrast to the controversy regarding the terminology and behavior of ovarian noninvasive low-grade serous tumors [atypical proliferative serous tumor (APST) and serous borderline tumor], little attention has been directed to their origin. Similarly, until recently, proliferative lesions in the fallopian tube had not been extensively studied. The recent proposal that ovarian high-grade serous carcinomas are derived from intraepithelial carcinoma in the fallopian tube prompted us to evaluate the possible role of fallopian tube in the genesis of low-grade serous tumors. We have identified a lesion, designated "papillary tubal hyperplasia (PTH)," characterized by small rounded clusters of tubal epithelial cells and small papillae, with or without associated psammoma bodies, that are present within the tubal lumen and which are frequently associated with APSTs. Twenty-two cases in this study were selected from a population-based study in Denmark of approximately 1000 patients with low-grade ovarian serous tumors in whom implants were identified on the fallopian tube. Seven additional cases were seen recently in consultation at The Johns Hopkins Hospital (JHH). These 7 cases were not associated with an ovarian tumor. PTH was found in 20 (91%) of the 22 cases in the Danish study. On the basis of this association of PTH with APSTs with implants and the close morphologic resemblance of PTH, not only to primary ovarian APSTs but also to noninvasive epithelial implants and endosalpingiosis, we speculate that the small papillae and clusters of cells from the fallopian tube implant on ovarian and peritoneal surfaces to produce these lesions. The 7 JHH cases of PTH that were not associated with an ovarian tumor support the view that PTH is the likely precursor lesion. We propose a model for the development of ovarian and extraovarian low-grade serous proliferations (APST, noninvasive epithelial implants, and endosalpingiosis) that postulates that all of these lesions are derived from PTH, which appears to be induced by chronic inflammation. If this hypothesis is confirmed, it can be concluded that low-grade and high-grade ovarian tumors develop from tubal epithelium and involve the ovary secondarily.
C onsiderable controversy has surrounded the terminology and behavior of noninvasive low-grade ovarian serous tumors [atypical proliferative serous tumors (APSTs) and serous borderline tumors (SBTs)], but little attention has been directed toward determining their origin. The most contentious issues regarding their terminology were resolved in 2003 by the Borderline Ovarian Tumor conference under the auspices of the National Cancer Institute, which deemed that the terms APST and SBT are synonymous. 17 Accordingly, APST and SBT have been used interchangeably in this report. The recent revelation that intraepithelial carcinoma in the fallopian tube is the likely precursor of most, if not all, ovarian high-grade serous carcinomas prompted us to reconsider the fallopian tube as a possible site of origin of low-grade serous tumors.
Previously, we reported that mucosal and luminal calcifications frequently surrounded by bland epithelium in the fallopian tube, so-called "salpingoliths," were significantly more frequently associated with APSTs than were all other ovarian neoplasms (P<0.001). 16 In that study, salpingoliths were found in 24% of stage I and in 51% of stage II and III APSTs. We were unable to determine whether these lesions arose in the fallopian tube and implanted on the ovary and peritoneum, arose in the ovary and implanted in the tube, or whether the tubal and ovarian lesions developed independently.
During the course of a large population-based study of ovarian low-grade serous tumors from Denmark, aimed at evaluating their clinicopathologic and epidemiologic features and at identifying biomarkers to assist in the distinction of noninvasive from invasive implants, we noted the frequent association with and close morphologic resemblance of a particular type of tubal hyperplasia, designated "papillary tubal hyperplasia (PTH)," to APSTs. PTH is characterized by small rounded clusters of tubal epithelial cells and small papillae, with or without associated psammoma bodies, floating within the tubal lumen. This study describes the morphologic features of this lesion and its association with ovarian APSTs, peritoneal implants, and endosalpingiosis.
MATERIALS AND METHODS

Case Selection
Twenty-two cases from a population-based study of approximately 1000 ovarian low-grade serous tumors in Denmark and 7 recent cases of PTH seen in consultation at The Johns Hopkins Hospital (JHH) Department of Pathology, Division of Gynecologic Pathology, constitute this descriptive analysis. Clinical information was obtained from a review of medical records and pathology reports from the Danish cases and from consultation letters, pathology reports, and communication with the referring pathologists or clinicians for the JHH consultation cases. One to 4 sections from fallopian tubes were examined in the Danish study and 2 to 21 sections from the JHH consult cases. It should be noted that in all cases the sections were representative sections only.
Danish Cases
The aims of the Danish study were to evaluate the clinicopathologic and epidemiologic features of ovarian low-grade serous tumors in the female population of Denmark. One specific aim was to determine whether immunohistochemical and molecular genetic analyses could distinguish noninvasive from invasive implants. This will be the subject of a future report. From among the 1000 tumors that qualified for the diagnosis of APST, a subset of cases with implants in the mesosalpinx for which fallopian tubes were available for microscopic review was selected for further study. It should be noted that, although one of us (R.J.K.) was aware of these tubal proliferations and their association with APSTs for some time, it was not the intent at the start of the Danish study to evaluate them. It was only during the course of selecting cases for immunohistochemical and molecular genetic analyses of the implants that we were again struck by the resemblance of the tubal lesions to APSTs and noninvasive implants and their high frequency in these tubes that led to the current investigation.
Johns Hopkins Consultation Cases
The 7 consultation cases were sent to us at approximately the same time as the analysis of the Danish cases was being performed. Although we have observed a number of such cases over the years, an exhaustive attempt to search for similar cases in our files was not undertaken.
Definition of PTH
Owing to the difficulty in the past in agreeing on what constitutes tubal hyperplasia, 3, 9, 14, 23 we restricted our definition to include only those tubal proliferations that exhibited papillary tufting and detached clusters of bland epithelium frequently, but not always, associated with psammona bodies. These clusters of epithelial cells and small papillae were found floating in the lumen or protruding from the tubal mucosa into the lumen and hence the lesion was termed "papillary tubal hyperplasia." As the number of papillae can vary considerably, for purposes of this study, we arbitrarily included only those cases in which a minimum of 3 papillae/section had been identified. Stratification of tubal cells alone was not sufficient for inclusion, as this finding, which in some instances is probably due to tangential sectioning, is often found in fallopian tubes without any other evidence of hyperplasia and is therefore considered a normal variant.
RESULTS
Microscopic Findings
Under low magnification the plical architecture has an abnormal, complex, "busy" appearance compared with normal architecture ( Figs. 1 A, B ). Under higher magnification the detached clusters of cells and small papillae floating in the tubal lumen are more clearly evident (Figs. [2] [3] [4] [5] . They are composed of a single layer of epithelium containing ciliated, secretory, and intraepithelial lymphocytes, identical to the cellular composition of the normal tubal mucosa. The intraepithelial lymphocytes are located just above the basement membrane and are smaller than the ciliated and secretory cells. They contain a small, hyperchromatic, round or convoluted nucleus that is surrounded by a clear space or halo (Figs. 6,7). These cells were previously termed "indifferent" cells and were thought to possibly be somatic stem cells of fallopian tube epithelium. 22 However, more recent studies have shown that they are lymphocytes that represent a form of mucosal-associated lymphoid tissue. 10 Rare clusters of epithelial cells are flat and some contain a vacuole similar to that seen in ovarian serous tumors. Other clusters contain slightly larger cells with eosinophilic cytoplasm similar to eosinophilic metaplastic cells in the endometrium. Mitotic figures are rarely seen. Both the secretory and ciliated cells are bland and bear no resemblance to serous tubal intraepithelial carcinoma. As observed in our previous study, 16 psammoma bodies can be found isolated in the tubal lumen or surrounded by a mantle of bland tubal epithelium, in which case they qualify as "salpingoliths" (Figs. 5, 6) . In addition to the tubal lumen, psammoma bodies are also present in the epithelium and lamina propria of the tube (Fig. 6 ).
A lesser degree of hyperplasia is characterized by small, raised tufts of epithelium that emanate from the tubal epithelium ( Fig. 8 ). As the hyperplasia evolves, the tufts enlarge and form round clusters of cells identical to the clusters and papillae floating in the lumen but still attached to the tubal mucosa. Their connection to the epithelium is tenuous and gives the impression that they are about to be pinched off (Figs. 7, 9) . In some instances these attached small papillae contain a psammoma body in the core (salpingolith), identical to those papillae floating in the lumen. Owing to the complex arrangement of tubal plicae, particularly in younger women, it is often difficult to be certain whether some of these papillary tufts without psammoma bodies are normal constituents of the tubal architecture cut tangentially or whether they are the earliest form of hyperplasia. To be conservative in determining the association of these lesions with APSTs, as indicated in the Materials and Methods section, we included only those in which there were at least 3 clusters/ papillae per section. The presence of associated psammoma bodies was a useful feature in classifying a specimen as PTH, as psammoma bodies are not a feature of normal fallopian tube epithelium. The morphologic similarity of PTH, APSTs, and noninvasive implants is striking ( Fig. 10 ).
PTH in Danish Cases
Patients ranged in age from 22 to 83 years, with a mean of 42 years and a median of 41.5 years. A more detailed description of the demographic findings will be presented in a future publication that describes the clinical and pathologic features of the entire cohort. The women in this study had a mean age approximately 10 years younger than that of the remaining cohort. In all other aspects they did not differ significantly. 
Tubal Findings
As noted in the Materials and Methods section, in the Danish study, a subset of cases with tubal implants was selected because adjacent tubal tissue was available for review (Table 1) . PTH was found in 20 (91%) of 22 cases and was not detected in 2 (9%) cases. The 2 cases in which PTH was not detected had only 1 section in each case available for review. In 15 (75%) of the 20 cases with PTH, papillae were found in all the sections of tube examined, whereas in 5 (25%) cases papillae were absent in some of the sections, indicating that the process may not diffusely involve the tube. It appeared as though the ampullary portion of the tube was more frequently and more extensively involved compared with the infundibulum and isthmus; however, in this study the ampulla was more frequently sampled than the other parts of the tube. The number of intraluminal papillae varied from as few as 3 per case (2 cases) to "too numerous to count" (6 cases). In the remaining cases the number of papillae ranged from 5 to 42. Psammoma bodies were found in 11 (50%) cases, ranging from a few (2 per case) to many (too numerous to count). They were located in the lamina propria of the tubal plicae, epithelium, and lumen. A chronic inflammatory infiltrate, confined to the lamina propria of the tube, was present in 8 (36%) of the 22 cases. One of these cases also demonstrated acute inflammation. Evidence of previous episodes of pelvic inflammatory disease based on agglutination of plicae, bridging of plicae across the tubal lumen, or loss of plicae resulting in hydrosalpinyx was found in 8 (36%) of the 22 cases.
As mentioned in the Materials and Methods section, all of the cases selected for study had implants involving the fallopian tube. They were noninvasive epithelial implants in 15 (68%) of the 22 cases, noninvasive desmoplastic implants in 4 (18%) cases, and invasive implants (metastatic low-grade serous carcinoma) in 3 (14%) cases. It should be noted that some noninvasive epithelial implants were surrounded by fibrotic tissue, but they did not have the typical appearance of desmoplastic implants in which the epithelial component merges with the stromal component and has a mesothelial appearance. The 3 invasive implants were all associated with invasive low-grade serous carcinomas of the ovary.
Associated Findings in the Ovary and Extraovarian Sites
The associated ovarian tumor was an APST in 19 cases and an APST with an invasive low-grade serous carcinoma in 3 cases (Table 2 ). In addition to the fallopian tube, noninvasive implants were identified in the omentum in 2 cases and on the uterine serosa in 1 case. Endosalpingiosis involving the omentum and tube was found in 6 (27%) cases.
PTH in Johns Hopkins Cases
The clinical and pathologic findings are summarized in Table 3 . A detailed description of the 7 cases is included in an appendix, Supplemental Digital Content 1, http://links.lww.com/PAS/A91.
In brief, among the 7 JHH consultation cases, the number of sections from the tubes ranged from 2 to 21. PTH was found in all sections in only 2 cases, indicating that the lesion can be focal. Psammoma bodies were detected in 4 (57%) of the 7 cases. Chronic salpingitis was present in 3 (43%) of the cases, one of which was severe and also acute. In the latter case there was pyosalpinx and marked destruction of the plicae, and in 2 other cases there was distortion of the plical architecture but no evidence of inflammation. Thus, there was evidence of pelvic inflammatory disease in 5 (71%) of the 7 cases. Endosalpingiosis was present in 4 (57%) cases and a noninvasive epithelial implant in another.
DISCUSSION
In 1969 Pauerstein and Woodruff wrote in the preface of their textbook on the fallopian tube "The era of indifference to the fallopian tube has passed." 22 This statement was more prophetic than timely because it took almost another half a century for indifference to turn to intense interest as investigators proposed that intraepithelial carcinoma in the fallopian tube was the long sought for precursor of ovarian high-grade serous carcinoma. 4, 5, 8, 12, 13, 19 As part of this renaissance in the role of the fallopian tube in ovarian carcinogenesis, we renewed our interest in exploring the link between tubal hyperplasia and ovarian low-grade serous tumors.
Proliferative lesions in the fallopian tube, other than carcinomas, have received relatively little attention. There is general agreement that tubal hyperplasia exists, but the criteria for its definition, including what constitutes the minimal degree of proliferation, have not been clarified. 3, 9, 11, 14, 22, 23 Similarly, investigators have debated whether tubal hyperplasia is significantly associated with APSTs. Two studies that investigated this relationship arrived at diametrically opposite conclusions. Robey and Silva 14 retrospectively reviewed representative sections of fallopian tubes from 99 women with SBTs and compared them with the fallopian tubes of 58 patients with cervical carcinoma and high-grade ovarian serous carcinoma. They found tubal hyperplasia in 68.7% of the SBT cases compared with 25.9% in the control group (P < 0.01). In contrast, Yanai-Inbar et al 23 analyzed fallopian tubes from 49 women with SBTs compared with a control criteria for tubal hyperplasia and the photomicrographs in these articles, we believe that the different conclusions that were reached are due to the use of different criteria for the diagnosis of tubal hyperplasia. Our analysis confirms that there are varying degrees of tubal hyperplasia. The earliest recognizable form begins with focal epithelial stratification, followed by a slight uplifting of the tubal epithelium that forms a small tuft. With increasing proliferation, the tuft expands and extends into the tubal lumen to form a small epithelial bud. The buds expand and form rounded papillae composed of cells identical to those in the tubal mucosa. The papillae can be solid, in which case they are classified as "clusters," or they can contain a central stromal core, in which case they are termed "papillae." As there appear to be variations on the same theme, we have used the terms interchangeably. As the tubal buds enlarge, they become more distinct, rounded, and appear to be pinched off and extruded into the tubal lumen. Psammoma bodies can be present in the center of the papillae or are "naked" without associated epithelium. Besides the papillae in the tubal lumen, psammoma bodies are located in the lamina propria and the tubal mucosa. It is these papillae and psammoma bodies that are the key diagnostic features of PTH. The presence and location of psammoma bodies are an intriguing aspect of this lesion, as they are often the dominant feature. Their location in the lumen, epithelium, and lamina propria suggests that they develop in the epithelium during the formation of an epithelial bud. It appears that the buds may then be either extruded into the tubal lumen or may invaginate into the underlying stroma. The epithelium subsequently degenerates, leaving a "naked" psammoma body in the tubal lumen or in the lamina propria. A similar process can occur in extratubal sites as well. In this study and in our experience it is not unusual to find a myriad of psammoma bodies coating peritoneal surfaces, notably the uterine serosa, ovaries, and bowel serosa, often with very little associated epithelium. We speculate that initially epithelium surrounded the psammoma bodies but then degenerated, leaving only "naked" psammoma bodies, which act as an irritant in the peritoneal cavity and induce fibrosis that can lead to adhesions and bowel obstruction. The different conclusions reached by Robey and Silva 14 and Yanai-Inbar et al 23 regarding the association of ovarian SBTs with tubal hyperplasia probably relate to the different criteria that were used to diagnose tubal hyperplasia. Specifically, PTH is frequently associated with APSTs, but lesser degrees of hyperplasia are not. Yanai-Inbar et al illustrate the very early budding stage (their Fig. 3 ) but not the fully developed free-floating epithelial clusters. 23 In contrast, Robey and Silva mention and illustrate the early budding stage and the detached luminal clusters of epithelial cells (their Fig. 1 ), but they do not specifically indicate how often this latter change was found in their cases. 14 The findings in this study strongly suggest that PTH is the most advanced stage of tubal hyperplasia, and it is this lesion that is associated with APSTs. We speculate that lesser degrees of tubal hyperplasia may not necessarily progress to PTH, and therefore are not significantly associated with APSTs. For that matter, not all PTHs progress to APSTs as illustrated by the 7 JHH cases in this study that were not associated with an ovarian tumor. It is conceivable that if the tubes in these cases were not removed PTH may have resulted in the development of an APST.
The fallopian tube has also been implicated in the development of endosalpingiosis. Sampson, 15 who first described endosalpingiosis, believed that it arose from the epithelium that was sloughed from fallopian tubes. Subsequently, Zinsser and Wheeler 24 in a study of 128 omenta removed at autopsy and surgery reported 16 (14. 8%) examples of endosalpingiosis. Of further interest in their study was the presence of an associated serous cystadenoma in 1 case and SBTs in 3 others. One of these latter cases was reported as a serous carcinoma with metastases, but the primary tumor and metastases were described as having numerous cilia. Therefore, on the basis of this observation and their 2 photomicrographs (their Figs. 8, 9 ), we interpret this as an SBT with noninvasive epithelial implants and endosalpingiosis. These investigators found no transition of mesothelium to endosalpingiosis. They also noted that there were no examples of endosalpingiosis in male patients, and therefore concluded that endosalpingiosis resulted from sloughing and implantation of tubal epithelium.
We postulate that PTH is responsible for the development of both endosalpingiosis and noninvasive epithelial implants even in the absence of an APST. Endosalpingiosis is composed of glands lined by a single layer of tubal-type epithelium. When endosalpingiosis exhibits papillary tufting or detachment of cell clusters or cribriform patterns and varying degrees of cytologic atypia, it is classified as "atypical endosalpingiosis." 2 As the latter becomes more florid it merges into what is classified as a "noninvasive epithelial implant." Endosalpingiosis frequently accompanies SBTs and has been reported to be as high as 40% in some series. 18 In our Danish population-based study of low-grade serous tumors, the prevalence of endosalpingiogsis was 10% (unpublished data). Accordingly, it appears that endosalpingiosis and noninvasive epithelial implants are part of a continuum of benign low-grade serous proliferations involving the peritoneum that result from implantation of tubal epithelium. Although sometimes noninvasive epithelial implants are embedded in fibrous tissue, they differ from noninvasive desmoplastic implants morphologically. The latter typically display a biphasic epithelial and spindle cell growth pattern often associated with a chronic inflammatory infiltrate. It is conceivable that some of these may develop in situ. In contrast, invasive implants are metastatic low-grade serous carcinomas from either a noninvasive low-grade ovarian serous carcinoma (micropapillary serous) or an invasive lowgrade serous carcinoma. 19 In this study, the 3 cases of invasive implants were all associated with a noninvasive ovarian low-grade serous carcinoma.
Another interesting observation in this study, as in our previous study on salpingoliths, 16 was the frequent association of chronic salpingitis and distorted tubal architecture consistent with previous pelvic inflammatory disease with PTH and endosalpingiosis. Zinsser and Wheeler 24 in their autopsy study reported that 14 (88%) of 16 cases of endosalpingiosis had evidence of chronic salpingitis either in the form of chronic inflammation or as distorted tubal architecture. It is well known that inflammation may stimulate proliferation of tubal epithelium; therefore, it is plausible that chronic salpingitis may play a role in the pathogenesis of PTH and endosalpingiosis. In this study, evidence of pelvic inflammatory disease in the form of chronic salpingitis or distorted tubal architecture was found in 35% to 70% of cases (Danish and JHH cases, respectively).
Three possible mechanisms can explain the association of PTH and APSTs. One is that the tubal and ovarian lesions arise independently, a process that has been termed a "field effect." A second is that the ovarian tumor is primary and that the clusters of cells and papillae in the tubal lumen are a secondary phenomenon. The third possibility is that the tubal lesion is primary and that the ovarian and extraovarian lesions (APST, noninvasive epithelial implants, and endosalpingiosis) are secondary. Robey and Silva 14 concluded that tubal hyperplasia and SBTs developed independently as a result of a so-called "field effect," as did McCaughey et al 7 in their study of SBTs and implants. This implies that SBTs develop from peritoneal mesothelium through a process of metaplasia resulting in their mu¨llerian phenotype. The concept of mu¨llerian metaplasia of the peritoneal mesothelium, although difficult to completely disprove has, however, no evidence to support it. In this study, the morphologic similarity of PTH, noninvasive epithelial implants, and APSTs is striking. All of these lesions, in addition to being composed of ciliated and secretory cells identical to those in normal fallopian tube epithelium, also contain intraepithelial lymphocytes, which are also found in the normal tubal epithelium. Invoking metaplasia of the peritoneum (mesothelium) to account for the development of this complex assortment of cells seems highly unlikely. In addition, in our experience, PAX 8, a mu¨llerian marker, is expressed in fallopian tube epithelium and APSTs, whereas calretinin, a mesothelial marker, is not. In contrast, the ovarian surface epithelium strongly expresses calretinin but not PAX 8 (unpublished data). Furthermore, psammoma bodies are an integral part of PTH as they are found in the majority of cases, and psammoma bodies are frequently associated with APSTs. In contrast, psammoma bodies are typically not associated with mesothelial proliferations, and when they are they are usually few in number. Finally, noninvasive epithelial implants, like endosalpingiosis, have not been reported in male patients. Notwithstanding rare reports of endometriosis in the prostate of men treated with estrogen, 1 there is no support for the argument that female sex steroid hormones are responsible for mu¨llerian metaplasia of the peritoneum leading to the development of endosalpingiosis and noninvasive epithelial implants in women. We believe that the most plausible explanation is that PTH is the precursor of all of these lesions as it was identified in 7 cases in this study in the absence of a primary ovarian tumor. Moreover, in 1 of these cases, a noninvasive epithelial implant was identified, and in 4 cases PTH was associated with endosalpingiosis.
On the basis of the findings in this study, we propose the following model for the origin and development of the entire spectrum of pelvic low-grade serous proliferations. Chronic inflammation induces a proliferation of tubal epithelium that can progress to PTH in some women. Epithelial clusters and papillae are shed and implant on ovarian and peritoneal surfaces. On the ovary the lesion is termed "cortical inclusion cyst," and when it involves extraovarian sites it is termed "endosalpingiosis." In contrast to cortical inclusion cysts lined by tubal-type epithelium, some cysts are lined by flat epithelium and represent invaginated clefts from the surface of the ovary that have been tangentially cut. Accordingly, there are 2 types of cortical inclusion cysts: one derived from invaginated surface epithelium and therefore of mesothelial origin and another resulting from implanted tubal epithelium and therefore of mu¨llerian origin. It is also conceivable that normal tubal epithelium can implant directly on the ovary at the time of ovulation when the ovarian surface epithelium is disrupted and the fimbria are in direct contact with the denuded ovarian surface. When endosalpingiosis exhibits a complex glandular arrangement with varying degrees of cytologic atypia, it qualifies for the diagnosis of "atypical endosalpingiosis," which merges imperceptibly into noninvasive epithelial implants. If mutation of KRAS or BRAF occurs in any of these lesions, an APST develops. 20 This model can explain the development not only of ovarian APSTs but also of noninvasive implants and APSTs involving pelvic and abdominal sites in the absence of an ovarian tumor.
As previously noted, one of the aims of our ongoing population-based study of ovarian low-grade serous tumors in Denmark is to identify biomarkers to assist in the distinction of noninvasive and invasive implants. Hence, the presence of PTH was not recorded in the data collection. We are therefore unable to determine the frequency of PTH in the study population.
In conclusion, we propose a model for the development of all low-grade serous proliferations involving ovarian and extraovarian sites (APSTs, noninvasive epithelial implants, and endosalpingiosis). The process begins with chronic inflammation leading to tubal hyperplasia, which, if it progresses to PTH, can shed and implant tubal epithelium on ovarian and peritoneal surfaces, resulting in a variety of Am J Surg Pathol Volume 35, Number 11, November 2011 Papillary Tubal Hyperplasia low-grade serous proliferations. If this hypothesis is confirmed, it would indicate that all ovarian serous tumors, both low and high grade, originate from the tubal epithelium and involve the ovary secondarily. Laury and associates 6 have reached a similar conclusion.
